Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Angel Yeast lança Saccharomyces Boulardii Bld-3 patenteada, uma cepa de levedura probiótica eficaz contra diarreia
  • USA - Français
  • USA - Deutsch
  • Latin America - español
  • USA - español
  • USA - English

(PRNewsfoto/Angel Yeast)

News provided by

Angel Yeast

Sep 02, 2021, 20:34 ET

Share this article

Share toX

Share this article

Share toX

YICHANG, China, 2 de setembro de 2021 /PRNewswire/ -- A Angel Yeast Co., Ltd ("Angel Yeast" ou "Angel"), uma empresa de leveduras de alta tecnologia listada na China, anunciou que sua equipe de P&D nutricional desenvolveu uma nova cepa de levedura probiótica, a Saccharomyces boulardii Bld-3 (S.boulardii Bld-3) e uma tecnologia de produção inovadora para o novo produto. A levedura probiótica patenteada foi desenvolvida para tratar diarreia e fortalecer os sistemas digestivo e imunológico em crianças e adultos.

Continue Reading
A Angel Yeast anunciou que desenvolveu uma nova cepa da levedura probiótica Saccharomyces boulardii Bld-3 (S. boulardii Bld-3) para tratar diarreia e fortalecer os sistemas digestivo e imunológico em crianças e adultos. (PRNewsfoto/Angel Yeast)
A Angel Yeast anunciou que desenvolveu uma nova cepa da levedura probiótica Saccharomyces boulardii Bld-3 (S. boulardii Bld-3) para tratar diarreia e fortalecer os sistemas digestivo e imunológico em crianças e adultos. (PRNewsfoto/Angel Yeast)

"Saccharomyces boulardii (S. boulardii) é uma espécie de probiótico que foi considerado uma intervenção nutricional crucial no tratamento da diarreia. A nova cepa de levedura probiótica desenvolvida pela Angel Nutrition & Health Technical Center, S.boulardii Bld-3, é outra adição inovadora à família S. boulardii, que tem se mostrado eficaz na aceleração da recuperação da diarreia aguda e é benéfica para a saúde intestinal no longo prazo", disse o Dr. Zhang Yan, CTO da Angel Nutritech, fundada em 1992 pela Angel Yeast com foco em nutrição e saúde humana para desenvolver e fornecer produtos acabados de destaque aos setores globais de cuidados humanos.

A COVID-19 levou mais pessoas a prestar atenção a sua saúde e a um maior foco em medidas de precaução e produtos de cuidados com a saúde que previnem doenças e fortalecem seus sistemas imunológicos. No Google Trends, as entradas de pesquisa "saúde intestinal" e "probiótico" tiveram vários picos durante a pandemia. Para cuidados gastrointestinais, as pesquisas por palavras-chave relacionadas a probióticos também bateram o recorde este ano, o que indica um maior reconhecimento de sua robusta capacidade de restaurar e manter um sistema digestivo saudável para os humanos.

O uso de S. boulardii para o tratamento de adultos e crianças com diarreia tem sido amplamente prescrito por médicos e gastroenterologistas há décadas, e sua eficácia para combater uma série de condições gastrointestinais está bem documentada na literatura médica. Um estudo publicado no Chinese Journal of Pediatrics concluiu que determinados tipos de probióticos podem reduzir a gravidade e a duração da diarreia. Entre eles, o Lactobacillus rhamnosus GG e o S. boulardii são os dois probióticos mais eficazes para o tratamento da diarreia.

Diferentemente do probiótico Lactobacillus, o S. boulardii Bld-3 da Angel é desenvolvido utilizando o processo de leito fluidizado de baixa temperatura. A tecnologia de proteção exclusiva da empresa permite que ela rapidamente forme uma concha densa de levedura que envolve os probióticos de levedura ativa presos do lado de dentro. Esse processo fortalece a resistência da levedura ao ácido gástrico e aos sais da bile, permitindo que seja aplicado em uma ampla variedade de produtos probióticos finais.

O S. boulardii Bld-3 da Angel é um ingrediente adequado para uma ampla série de suplementos alimentares probióticos. Graças ao maior tamanho dos probióticos de levedura, que são dez vezes maiores do que os probióticos de Lactobacillus, é mais provável que eles formem um efeito de ocupação de espaço no trato intestinal e sejam resistentes a antibióticos.

Um dos maiores fornecedores mundiais de derivados de leveduras, a Angel Yeast tem mais de três décadas de experiência no desenvolvimento e produção de produtos de levedura. Além do S. boulardii Bld-3, a Angel Yeast também produz probióticos de Saccharomyces cerevisiae e mais uma diversidade de ingredientes funcionais de leveduras, com vários novos produtos no pipeline, como o Kluyveromyces marxianus. Atualmente, os probióticos produzidos pela Angel Yeast são vendidos para a Europa e América do Norte.

Sobre a Angel Yeast 

Fundada em 1986, a Angel Yeast Co., Ltd é especializada na produção de levedura e derivados de levedura. Sua linha de produtos inclui leveduras e ingredientes para panificação, soluções para dim sum chinês, extrato de levedura, saúde humana, nutrição animal, cuidados para plantas, fabricação de cerveja e biocombustíveis, nutrição microbiana e enzimas. Atualmente, a Angel Yeast tem 11 bases de produção internacionais avançadas na China, Egito e Rússia e fornece produtos e serviços para mais de 150 países e regiões do mundo.

Foto - https://mma.prnewswire.com/media/1607716/1.jpg 
Logo - https://mma.prnewswire.com/media/1586948/angel_logo_Logo.jpg

FONTE Angel Yeast

Related Links

www.angelyeast.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

Clôture des finales de la coupe Angel Yeast et de la conférence sur le développement de l'industrie

Clôture des finales de la coupe Angel Yeast et de la conférence sur le développement de l'industrie

Les finales du 8e concours Angel Yeast Cup Chinese Fermented Dim Sum et la 12e conférence sur le développement de l'industrie des aliments à base de...

Finale des Angel Yeast Cup und Abschluss der Industry Development Conference

Finale des Angel Yeast Cup und Abschluss der Industry Development Conference

Die Finale des 8. Angel Yeast Cup Chinese Fermented Dim Sum Contest und die 12. Fermented Flour-Based Food Industry Development Conference (Konferenz ...

More Releases From This Source

Explore

Food & Beverages

Food & Beverages

Health Care & Hospitals

Health Care & Hospitals

Biotechnology

Biotechnology

Fitness/Wellness

Fitness/Wellness

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.